Clinical context

Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist discussed in official labels and clinical trials for metabolic indications.

Educational reference only. Pepski does not provide treatment recommendations or personal dosing instructions.

Where to verify clinical details

Use official labels and clinical trial registries for current indication, safety, and studied-use information.

Pepski tracking context

Pepski helps keep logs, reminders, notes, and progress history organised. It is not a prescriber and does not replace professional guidance.

Join the waitlist